CTOs on the Move


 
Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine. We offer a growing portfolio of more than 7,500 products, including prescription generic, branded generic, brand-name and biosimilar drugs, as well as over-the-counter (OTC) remedies. We market our products in more than 165 countries and territories, and every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world. Mylans mission is grounded in our belief that every person matters and should have the opportunity to live the healthiest life possible. We have ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.mylan.com
  • 1000 Mylan Boulevard
    Canonsburg, PA USA 15317
  • Phone: 724.514.1800

Executives

Name Title Contact Details
Matthew Smith
Global Executive Director - Cyber and Information Security Profile
Ramkumar Rayapureddy
Global Chief Information Officer Profile
Franklin Donahoe
Chief Information Security Officer Profile
Franklin Donahoe
Chief Information Security Officer Profile

Similar Companies

Kalypsys

Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developed. We seamlessly integrate our capabilities in drug discovery, medicinal chemistry and translational medicine with proprietary automated

Pharmacy OneSource

Pharmacy OneSource is a Middleton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cary Pharmaceuticals Inc

Cary Pharmaceuticals Inc is a Great Falls, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

L.B. Bohle

L.B. Bohle, LLC is a Warminster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

UniQure

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.